Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Filleron

Showing results (81-90 of 199) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancerSébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
Anti-TNF, a magic bullet in cancer immunotherapy?Anne Montfort, Carine Dufau, Céline Colacios, et al.
ERJ Open Research|July 22, 2021
Feasibility of comprehensive genotyping specimens from radial endobronchial ultrasonography and electromagnetic navigation bronchoscopyMaxime Robin, Laurent Mhanna, Leonor Chaltiel, et al.
JAMA Network Open|December 21, 2021
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic ReviewThomas Filleron, Marine Bachelier, Julien Mazieres, et al.
BMC Cancer|August 2, 2020
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trialThomas Filleron, Sophie Le Guellec, Christine Chevreau, et al.
European Journal of Epidemiology|October 21, 2025
Estimating overall survival by combining administrative and hospital death data: a methodological challengePierre-Yves Cren, Clémence Leguillette, Franck Craynest, et al.
The American Journal of Surgical Pathology|May 10, 2016
Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group DatabaseSophie Le Guellec, Anne-Valérie Decouvelaere, Thomas Filleron, et al.
BJU International|April 2, 2014
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancerMathieu Roumiguié, Jean-Baptiste Beauval, Thomas Filleron, et al.
Histopathology|August 24, 2018
Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?Margot Gaspard, Laurence Lamant, Emilie Tournier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2011
Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucoseLawrence Oliver Dierickx, Eric Huyghe, Daniela Nogueira, et al.
Pageof 20

Showing results (81-90 of 199) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancerSébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
Anti-TNF, a magic bullet in cancer immunotherapy?Anne Montfort, Carine Dufau, Céline Colacios, et al.
ERJ Open Research|July 22, 2021
Feasibility of comprehensive genotyping specimens from radial endobronchial ultrasonography and electromagnetic navigation bronchoscopyMaxime Robin, Laurent Mhanna, Leonor Chaltiel, et al.
JAMA Network Open|December 21, 2021
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic ReviewThomas Filleron, Marine Bachelier, Julien Mazieres, et al.
BMC Cancer|August 2, 2020
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trialThomas Filleron, Sophie Le Guellec, Christine Chevreau, et al.
European Journal of Epidemiology|October 21, 2025
Estimating overall survival by combining administrative and hospital death data: a methodological challengePierre-Yves Cren, Clémence Leguillette, Franck Craynest, et al.
The American Journal of Surgical Pathology|May 10, 2016
Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group DatabaseSophie Le Guellec, Anne-Valérie Decouvelaere, Thomas Filleron, et al.
BJU International|April 2, 2014
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancerMathieu Roumiguié, Jean-Baptiste Beauval, Thomas Filleron, et al.
Histopathology|August 24, 2018
Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?Margot Gaspard, Laurence Lamant, Emilie Tournier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2011
Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucoseLawrence Oliver Dierickx, Eric Huyghe, Daniela Nogueira, et al.
Pageof 20